Details
Stereochemistry | RACEMIC |
Molecular Formula | C6H12O4 |
Molecular Weight | 148.1571 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)(CCO)CC(O)=O
InChI
InChIKey=KJTLQQUUPVSXIM-UHFFFAOYSA-N
InChI=1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Identification of a gene cluster for the mevalonate pathway in Lactobacillus helveticus. | 2001 |
|
In vivo prenylation analysis of Ras and Rho proteins. | 2001 |
|
Isoprene increases thermotolerance of fosmidomycin-fed leaves. | 2001 Apr |
|
Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. | 2001 Apr |
|
Synthetic applications of epoxide hydrolases. | 2001 Apr |
|
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. | 2001 Aug |
|
Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure. | 2001 Dec |
|
Statins and their potential for osteoporosis. | 2001 Dec |
|
Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation. | 2001 Feb |
|
Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. | 2001 Jan |
|
Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation. | 2001 Jan |
|
Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis. | 2001 Jul |
|
Biosynthesis of 2-methyl-3-buten-2-ol emitted from needles of Pinus ponderosa via the non-mevalonate DOXP/MEP pathway of isoprenoid formation. | 2001 Jun |
|
Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation. | 2001 Jun |
|
HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. | 2001 Jun |
|
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. | 2001 Jun |
|
Dose-dependent effects of lovastatin on cell cycle progression. Distinct requirement of cholesterol and non-sterol mevalonate derivatives. | 2001 Jun 29 |
|
The in vitro inhibitory effect of tannin derivatives on 3-hydroxy-3-methylglutaryl-coenzyme a reductase on vero cells. | 2001 May |
|
NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells. | 2001 May |
|
Lovastatin controls signal transduction in vascular smooth muscle cells by modulating phosphorylation levels of mevalonate-independent pathways. | 2001 May-Jun |
|
Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes. | 2001 Nov 2 |
|
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. | 2001 Sep |
|
The genetics and molecular genetics of terpene and sterol origami. | 2002 Apr |
|
Incorporation of [1-(13)C]1-deoxy-D-xylulose into isoprenoids of the liverwort Conocephalum conicum. | 2002 Feb |
|
Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. | 2002 Feb 26 |
|
Biosynthesis of zeaxanthin via mevalonate in Paracoccus species strain PTA-3335. A product-based retrobiosynthetic study. | 2002 Feb 8 |
|
Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB. | 2002 Mar 22 |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
150-97-0
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
DB03518
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
17710
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
7681
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
100000076067
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
25351
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
m7512
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB14571MIG
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
DTXSID5040546
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
MEVALONIC ACID
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
449
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
S5UOB36OCZ
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD